{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:56:51Z","timestamp":1791014211440,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1124\/jpet.103.053819","type":"journal-article","created":{"date-parts":[[2003,9,19]],"date-time":"2003-09-19T00:50:21Z","timestamp":1063932621000},"page":"349-355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":122,"title":["Inhibition of Inflammation and Remodeling by Roflumilast and Dexamethasone in Murine Chronic Asthma"],"prefix":"10.1016","volume":"307","author":[{"given":"Rakesh K.","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristan","family":"Herbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Wollin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Beume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne C.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.103.053819_bib1","doi-asserted-by":"crossref","unstructured":"Almawi WY and Melemedjian OK (2002) Negative regulation of nuclear factor-\u03baB activation and function by glucocorticoids. J Mol Endocrinol 28: 69\u201378.","DOI":"10.1677\/jme.0.0280069"},{"key":"10.1124\/jpet.103.053819_bib2","doi-asserted-by":"crossref","unstructured":"Barsig J, Leung B, Bundschuh DS, Wollin L, Beume R, and Liew FY (2001) Protection by the phosphodiesterase-4 inhibitor roflumilast of mice against collagen-induced arthritis. Ann Rheum Dis 60: 156S.","DOI":"10.1136\/annrheumdis-2001.1147"},{"key":"10.1124\/jpet.103.053819_bib3","doi-asserted-by":"crossref","unstructured":"Blyth DI, Pedrick MS, Savage TJ, Bright H, Beesley JE, and Sanjar S (1998) Induction, duration and resolution of airway goblet cell hyperplasia in a murine model of atopic asthma: effect of concurrent infection with respiratory syncytial virus and response to dexamethasone. Am J Respir Cell Mol Biol 19: 38\u201354.","DOI":"10.1165\/ajrcmb.19.1.2930"},{"key":"10.1124\/jpet.103.053819_bib4","doi-asserted-by":"crossref","unstructured":"Blyth DI, Wharton TF, Pedrick MS, Savage TJ, and Sanjar S (2000) Airway subepithelial fibrosis in a murine model of atopic asthma: suppression by dexamethasone or anti-interleukin-5 antibody. Am J Respir Cell Mol Biol 23: 241\u2013246.","DOI":"10.1165\/ajrcmb.23.2.3999"},{"key":"10.1124\/jpet.103.053819_bib5","doi-asserted-by":"crossref","unstructured":"Bousquet J, Jeffery PK, Busse WW, Johnson M, and Vignola A (2000) Asthma: from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 161: 1720\u20131745.","DOI":"10.1164\/ajrccm.161.5.9903102"},{"key":"10.1124\/jpet.103.053819_bib6","doi-asserted-by":"crossref","unstructured":"Bundschuh DS, Eltze M, Barsig J, Wollin L, Hatzelmann A, and Beume R (2001) In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor. J Pharmacol Exp Ther 297: 280\u2013290.","DOI":"10.1016\/S0022-3565(24)29538-0"},{"key":"10.1124\/jpet.103.053819_bib7","doi-asserted-by":"crossref","unstructured":"Chetta A, Foresi A, Del Donno M, Consigli GF, Bertorelli G, Pesci A, Barbee RA, and Olivieri D (1996) Bronchial responsiveness to distilled water and methacholine and its relationship to inflammation and remodeling of the airways in asthma. Am J Respir Crit Care Med 153: 910\u2013917.","DOI":"10.1164\/ajrccm.153.3.8630572"},{"key":"10.1124\/jpet.103.053819_bib8","doi-asserted-by":"crossref","unstructured":"Compton CH, Gubb J, Nieman R, Edelson J, Amit O, Bakst A, Ayres JG, Creemers JPHM, Schultze-Werninghaus G, Brambilla C, and Barnes NC (2001) Cilomilast, a selective phosphodiesterase-4i nhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study. Lancet 358: 265\u2013270.","DOI":"10.1016\/S0140-6736(01)05481-2"},{"key":"10.1124\/jpet.103.053819_bib9","doi-asserted-by":"crossref","unstructured":"Conti M, Richter W, Mehats C, Livera G, Park JY, and Jin C (2003) Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling. J Biol Chem 278: 5463\u20135496.","DOI":"10.1074\/jbc.R200029200"},{"key":"10.1124\/jpet.103.053819_bib10","doi-asserted-by":"crossref","unstructured":"Davies DE, Wicks J, Powell RM, Puddicombe SM, and Holgate ST (2003) Airway remodeling in asthma: new insights. J Allergy Clin Immunol 111: 215\u2013225.","DOI":"10.1067\/mai.2003.128"},{"key":"10.1124\/jpet.103.053819_bib11","doi-asserted-by":"crossref","unstructured":"Fleming CM, He H, Ciota A, Perkins D, and Finn PW (2001) Administration of pentoxifylline during allergen sensitization dissociates pulmonary allergic inflammation from airway hyperresponsiveness. J Immunol 167: 1703\u20131711.","DOI":"10.4049\/jimmunol.167.3.1703"},{"key":"10.1124\/jpet.103.053819_bib12","doi-asserted-by":"crossref","unstructured":"Foster PS, Ming Y, Matthei KI, Young IG, Temelkovski J, and Kumar RK (2000) Dissociation of inflammatory and epithelial responses in a murine model of chronic asthma. Lab Investig 80: 655\u2013662.","DOI":"10.1038\/labinvest.3780068"},{"key":"10.1124\/jpet.103.053819_bib13","doi-asserted-by":"crossref","unstructured":"Haddad JJ, Land SC, Tarnow-Mordi WO, Zembala M, Kowalczyk D, and Lauterbach R (2002) Immunopharmacological potential of selective phosphodiesterase inhibition. II. Evidence for the involvement of an inhibitory-\u03baB\/nuclear factor-\u03baB-sensitive pathway in alveolar epithelial cells. J Pharmacol Exp Ther 300: 567\u2013576.","DOI":"10.1124\/jpet.300.2.567"},{"key":"10.1124\/jpet.103.053819_bib14","doi-asserted-by":"crossref","unstructured":"Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG, and Gelfand EW (1997) Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 156: 766\u2013775.","DOI":"10.1164\/ajrccm.156.3.9606031"},{"key":"10.1124\/jpet.103.053819_bib15","doi-asserted-by":"crossref","unstructured":"Hatzelmann A and Schudt C (2001) Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro. J Pharmacol Exp Ther 297: 267\u2013279.","DOI":"10.1016\/S0022-3565(24)29537-9"},{"key":"10.1124\/jpet.103.053819_bib16","doi-asserted-by":"crossref","unstructured":"Hoshino M, Nakamura Y, Sim JJ, Shimojo J, and Isogai S (1998a) Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J Allergy Clin Immunol 102: 783\u2013788.","DOI":"10.1016\/S0091-6749(98)70018-1"},{"key":"10.1124\/jpet.103.053819_bib17","doi-asserted-by":"crossref","unstructured":"Hoshino M, Nakamura Y, Sim JJ, Yamashiro Y, Uchida K, Hosaka K, and Isogai S (1998b) Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-I expression in bronchial asthma. Clin Exp Allergy 28: 568\u2013577.","DOI":"10.1046\/j.1365-2222.1998.00277.x"},{"key":"10.1124\/jpet.103.053819_bib18","doi-asserted-by":"crossref","unstructured":"Houslay MD and Adams RD (2003) PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem J 370: 1\u201318.","DOI":"10.1042\/bj20021698"},{"key":"10.1124\/jpet.103.053819_bib19","doi-asserted-by":"crossref","unstructured":"Howarth PH (2001) The influence of pharmacological therapy on airway remodeling in asthma, in Airway Remodeling (Howarth PH, Wilson JW, Bousquet J, Rak S, and Pauwels RA eds) pp 167\u2013188, Marcel Dekker, New York.","DOI":"10.1201\/9781420002751"},{"key":"10.1124\/jpet.103.053819_bib20","doi-asserted-by":"crossref","unstructured":"Kanehiro A, Ikemura T, Makela MJ, Lahn M, Joetham A, Dakhama A, and Gelfand EW (2001) Inhibition of phosphodiesterase 4 attenuates airway hyperresponsiveness and airway inflammation in a model of secondary allergen challenge. Am J Respir Crit Care Med 163: 173\u2013184.","DOI":"10.1164\/ajrccm.163.1.2001118"},{"key":"10.1124\/jpet.103.053819_bib21","doi-asserted-by":"crossref","unstructured":"Kohyama T, Liu X, Wen FQ, Zhu YK, Wang H, Kim HJ, Takizawa H, Cieslinski LB, Barnette MS, and Rennard SI (2002) PDE4 inhibitors attenuate fibroblast chemotaxis and contraction of native collagen gels. Am J Respir Cell Mol Biol 26: 694\u2013701.","DOI":"10.1165\/ajrcmb.26.6.4743"},{"key":"10.1124\/jpet.103.053819_bib22","doi-asserted-by":"crossref","unstructured":"Kremsner PG, Grundmann H, Neifer S, Sliwa K, Sahlmuller G, Hegenscheid B, and Bienzle U (1991) Pentoxifylline prevents murine cerebral malaria. J Infect Dis 164: 605\u2013608.","DOI":"10.1093\/infdis\/164.3.605"},{"key":"10.1124\/jpet.103.053819_bib23","doi-asserted-by":"crossref","unstructured":"Kumar RK (2001) Understanding airway wall remodeling in asthma: a basis for improvements in therapy? Pharmacol Ther 91: 93\u2013104.","DOI":"10.1016\/S0163-7258(01)00149-8"},{"key":"10.1124\/jpet.103.053819_bib24","doi-asserted-by":"crossref","unstructured":"Kumar RK and Foster PS (2002) Modeling allergic asthma in mice: pitfalls and opportunities. Am J Respir Cell Mol Biol 27: 267\u2013272.","DOI":"10.1165\/rcmb.F248"},{"key":"10.1124\/jpet.103.053819_bib25","doi-asserted-by":"crossref","unstructured":"Kumar RK, Thomas PS, Seetoo DQ, Herbert C, McKenzie AN, Foster PS, and Lloyd AR (2002) Eotaxin expression by epithelial cells and plasma cells in chronic asthma. Lab Investig 82: 495\u2013504.","DOI":"10.1038\/labinvest.3780442"},{"key":"10.1124\/jpet.103.053819_bib26","doi-asserted-by":"crossref","unstructured":"Niimi A, Matsumoto H, Amitani R, Nakano Y, Mishima M, Minakuchi M, Nishimura K, Itoh H, and Izumi T (2000) Airway wall thickness in asthma assessed by computed tomography: relation to clinical indices. Am J Respir Crit Care Med 162: 1518\u20131523.","DOI":"10.1164\/ajrccm.162.4.9909044"},{"key":"10.1124\/jpet.103.053819_bib27","doi-asserted-by":"crossref","unstructured":"Poynter ME, Irvin CG, and Janssen-Heininger YM (2002) Rapid activation of nuclear factor-\u03baB in airway epithelium in a murine model of allergic airway inflammation. Am J Pathol 160: 1325\u20131334.","DOI":"10.1016\/S0002-9440(10)62559-X"},{"key":"10.1124\/jpet.103.053819_bib28","doi-asserted-by":"crossref","unstructured":"Rott O, Cash E, and Fleischer B (1993) Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type-1 but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats. Eur J Immunol 23: 1745\u20131751.","DOI":"10.1002\/eji.1830230802"},{"key":"10.1124\/jpet.103.053819_bib29","doi-asserted-by":"crossref","unstructured":"Schmidt DT, Watson N, Dent G, Ruhlmann E, Branscheid D, Magnussen H, and Rabe KF (2000) The effect of selective and non-selective phosphodiesterase inhibitors on allergen- and leukotriene C4-induced contractions in passively sensitized human airways. Br J Pharmacol 131: 1607\u20131618.","DOI":"10.1038\/sj.bjp.0703725"},{"key":"10.1124\/jpet.103.053819_bib30","doi-asserted-by":"crossref","unstructured":"Schudt C, Tenor H, and Hatzelmann A (1995) PDE isoenzymes as targets for anti-asthma drugs. Eur Respir J 8: 1179\u20131183.","DOI":"10.1183\/09031936.95.08071179"},{"key":"10.1124\/jpet.103.053819_bib31","doi-asserted-by":"crossref","unstructured":"Sont JK, Willems LNA, Bel EH, van Krieken HJM, Vendenbroucke JP, Sterk PJ, and the AMPUL Study Group (1999) Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. Am J Respir Crit Care Med 159: 1043\u20131051.","DOI":"10.1164\/ajrccm.159.4.9806052"},{"key":"10.1124\/jpet.103.053819_bib32","doi-asserted-by":"crossref","unstructured":"Souness JE, Houghton C, Sardar N, and Withnall MT (1999) Suppression of anti-CD3-induced interleukin-4 and interleukin-5 release from splenocytes of Mesocestoides corti-infected BALB\/c mice by phosphodiesterase 4 inhibitors. Biochem Pharmacol 58: 991\u2013999.","DOI":"10.1016\/S0006-2952(99)00176-8"},{"key":"10.1124\/jpet.103.053819_bib33","doi-asserted-by":"crossref","unstructured":"Temelkovski J, Hogan SP, Shepherd DP, Foster PS, and Kumar RK (1998) An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 53: 849\u2013856.","DOI":"10.1136\/thx.53.10.849"},{"key":"10.1124\/jpet.103.053819_bib34","doi-asserted-by":"crossref","unstructured":"Timmer W, Leclerc V, Birraux G, Neuhauser M, Hatzelmann A, Bethke T, and Wurst W (2002) The new phosphodiesterase 4 inhibitor roflumilast is efficacious in exercise-induced asthma and leads to suppression of LPS-stimulated TNF-\u03b1 ex vivo. J Clin Pharmacol 42: 297\u2013303.","DOI":"10.1177\/00912700222011328"},{"key":"10.1124\/jpet.103.053819_bib35","doi-asserted-by":"crossref","unstructured":"Torphy TJ (1998) Phosphodiesterase isozymes: molecular targets for novel anti-asthma agents. Am J Respir Crit Care Med 157: 351\u2013370.","DOI":"10.1164\/ajrccm.157.2.9708012"},{"key":"10.1124\/jpet.103.053819_bib36","doi-asserted-by":"crossref","unstructured":"Trifilieff A, El-Hashim A, and Bertrand C (2000) Time course of inflammatory and remodeling events in a murine model of asthma: effect of steroid treatment. Am J Physiol Lung Cell Mol Physiol 279: L1120\u2013L1128.","DOI":"10.1152\/ajplung.2000.279.6.L1120"},{"key":"10.1124\/jpet.103.053819_bib37","doi-asserted-by":"crossref","unstructured":"Vanacker NJ, Palmans E, Kips JC, and Pauwels RA (2001) Fluticasone inhibits but does not reverse allergen-induced structural airway changes. Am J Respir Crit Care Med 163: 674\u2013679.","DOI":"10.1164\/ajrccm.163.3.2004160"},{"key":"10.1124\/jpet.103.053819_bib38","doi-asserted-by":"crossref","unstructured":"Verghese MW, McConnell RT, Strickland AB, Gooding RC, Stimpson SA, Yarnall DP, Taylor JD, and Furdon PJ (1995) Differential regulation of human monocyte-derived TNF\u03b1 and IL-1\u03b2 by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors. J Pharmacol Exp Ther 272: 1313\u20131320.","DOI":"10.1016\/S0022-3565(25)24562-1"},{"key":"10.1124\/jpet.103.053819_bib39","doi-asserted-by":"crossref","unstructured":"Weston MC, Anderson N, and Peachell PT (1997) Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function. Br J Pharmacol 121: 287\u2013295.","DOI":"10.1038\/sj.bjp.0701115"},{"key":"10.1124\/jpet.103.053819_bib40","unstructured":"Wollin L, Barsig J, Bundschuh DS, Marx D, and Beume R (2002) PDE4-specific inhibition of airway hyperresponsiveness and pulmonary inflammation in rats: roflumilast versus rolipram, piclamilast and cilomilast. Am J Respir Crit Care Med 165: A311."}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524309656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524309656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.103.053819","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T14:34:11Z","timestamp":1739975651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524309656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["S0022356524309656"],"URL":"https:\/\/doi.org\/10.1124\/jpet.103.053819","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2003,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Inflammation and Remodeling by Roflumilast and Dexamethasone in Murine Chronic Asthma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.103.053819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2003 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}